| |
| |
|
| Insider
Information: |
Mainolfi Nello |
| Relationship: |
|
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
615,570 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
615,570 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kymera Therapeutics, Inc. |
KYMR |
|
2024-01-02 |
615,570 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KYMR |
Kymera Therapeutics, Inc. |
President and CEOOfficer |
• • – |
2020-08-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
376,199 |
|
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-08 |
4 |
AS |
$34.81 |
$347,832 |
D/D |
(9,939) |
376,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-09 |
4 |
AS |
$33.58 |
$767,750 |
D/D |
(22,794) |
376,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-12 |
4 |
AS |
$32.29 |
$497,981 |
D/D |
(15,267) |
376,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-08 |
4 |
OE |
$2.08 |
$20,673 |
D/D |
9,939 |
386,138 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-13 |
4 |
OE |
$2.08 |
$31,200 |
D/D |
15,000 |
391,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-15 |
4 |
AS |
$40.29 |
$199,039 |
D/D |
(4,940) |
391,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-19 |
4 |
AS |
$40.00 |
$26,121 |
D/D |
(653) |
391,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-12 |
4 |
OE |
$2.08 |
$31,755 |
D/D |
15,267 |
391,466 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-15 |
4 |
OE |
$2.08 |
$10,275 |
D/D |
4,940 |
396,139 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-19 |
4 |
OE |
$2.08 |
$13,838 |
D/D |
6,653 |
397,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-22 |
4 |
AS |
$40.26 |
$441,182 |
D/D |
(10,959) |
397,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-23 |
4 |
AS |
$40.01 |
$27,208 |
D/D |
(680) |
397,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-26 |
4 |
AS |
$40.18 |
$111,229 |
D/D |
(2,768) |
397,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-05-12 |
4 |
AS |
$50.05 |
$412,677 |
D/D |
(8,245) |
397,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-23 |
4 |
OE |
$2.08 |
$1,414 |
D/D |
680 |
397,879 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-09 |
4 |
OE |
$2.08 |
$47,412 |
D/D |
22,794 |
398,993 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-26 |
4 |
OE |
$2.08 |
$5,757 |
D/D |
2,768 |
399,967 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-05-12 |
4 |
OE |
$2.08 |
$17,150 |
D/D |
8,245 |
405,444 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-22 |
4 |
OE |
$2.08 |
$22,795 |
D/D |
10,959 |
408,158 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-05-19 |
4 |
OE |
$2.08 |
$31,200 |
D/D |
15,000 |
412,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-07 |
4 |
AS |
$50.14 |
$638,040 |
D/D |
(12,724) |
412,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-08 |
4 |
AS |
$50.00 |
$13,500 |
D/D |
(270) |
412,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-09 |
4 |
AS |
$50.02 |
$287,721 |
D/D |
(5,752) |
412,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-10 |
4 |
AS |
$50.63 |
$1,182,106 |
D/D |
(23,009) |
412,199 |
0 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
